Optimal allocation of vaccines in a pandemic
综述了大流行期间稀缺疫苗的分配方法，比较了价格与非价格优先排序标准，指出基于流行病学标准可能优于健康风险标准，并强调关键权衡研究不足。
Abstract This paper provides an overview of approaches to the allocation of scarce vaccine doses during a pandemic. Price and non-price methods are outlined to determine whom to prioritize. It is argued that depending on viral and vaccine properties, it may be superior to use epidemiological criteria than health risk criteria for prioritization. The paper concludes by noting that the key trade-offs between health risk and epidemiological properties have received too little study to systematically inform allocation during a public health emergency. Moreover, the evaluation criteria for vaccines themselves need to be adjusted to take potential short-term scarcity into account.